Cardiopulmonary function in fibrodysplasia ossificans progressiva

Area of Science:

• Pulmonary Medicine
• Cardiology
• Rare Genetic Diseases

Background:

• Fibrodysplasia ossificans progressiva (FOP) is a rare genetic disorder characterized by progressive heterotopic ossification.
• Cardiopulmonary complications are a significant concern in FOP, impacting patient morbidity and mortality.
• Understanding the specific cardiopulmonary manifestations is crucial for managing patients with FOP.

Purpose of the Study:

• To evaluate the cardiopulmonary function in patients diagnosed with fibrodysplasia ossificans progressiva.
• To identify potential cardiac abnormalities and assess the extent of respiratory impairment in FOP patients.
• To determine factors influencing the severity of chest restriction and respiratory compromise.

Main Methods:

• Cardiopulmonary function tests were conducted on a cohort of 21 patients with FOP.
• Evaluations included electrocardiograms (ECGs) and spirometry to assess cardiac and pulmonary status.
• Data were analyzed to correlate chest restriction severity with demographic and clinical factors.

Main Results:

• No instances of cardiac enlargement or failure were detected in the study group.
• Six patients (approximately 28%) exhibited abnormal electrocardiograms, suggesting subclinical cardiac involvement.
• All patients demonstrated marked restrictive spirometry results, attributed to chest wall fixation and reliance on diaphragmatic breathing.

Conclusions:

• Cardiopulmonary function in FOP is primarily characterized by significant respiratory restriction, not cardiac failure.
• The severity of chest restriction in FOP is not correlated with age, sex, disease duration, or physical disability.
• Chest infections represent the most substantial life-threatening risk for FOP patients due to compromised pulmonary reserve, necessitating prophylactic strategies.